- Home
- ACHV vs ALAR Comparison
ACHV vs ALAR Comparison
Compare ACHV & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- ALAR
- Stock Information
- Founded
- ACHV N/A
- ALAR 2013
- Country
- ACHV United States
- ALAR Israel
- Employees
- ACHV N/A
- ALAR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ALAR Computer Software: Prepackaged Software
- Sector
- ACHV Health Care
- ALAR Technology
- Exchange
- ACHV Nasdaq
- ALAR Nasdaq
- Market Cap
- ACHV 131.3M
- ALAR 116.1M
- IPO Year
- ACHV N/A
- ALAR 2018
- Fundamental
- Price
- ACHV $2.93
- ALAR $14.87
- Analyst Decision
- ACHV Strong Buy
- ALAR Strong Buy
- Analyst Count
- ACHV 2
- ALAR 1
- Target Price
- ACHV $16.00
- ALAR $27.00
- AVG Volume (30 Days)
- ACHV 1.5M
- ALAR 128.5K
- Earning Date
- ACHV 11-06-2025
- ALAR 08-28-2025
- Dividend Yield
- ACHV N/A
- ALAR N/A
- EPS Growth
- ACHV N/A
- ALAR N/A
- EPS
- ACHV N/A
- ALAR 0.07
- Revenue
- ACHV N/A
- ALAR $30,488,000.00
- Revenue This Year
- ACHV N/A
- ALAR $11.54
- Revenue Next Year
- ACHV N/A
- ALAR $19.42
- P/E Ratio
- ACHV N/A
- ALAR $19.69
- Revenue Growth
- ACHV N/A
- ALAR N/A
- 52 Week Low
- ACHV $1.84
- ALAR $5.45
- 52 Week High
- ACHV $5.31
- ALAR $21.50
- Technical
- Relative Strength Index (RSI)
- ACHV 54.19
- ALAR 50.84
- Support Level
- ACHV $2.68
- ALAR $13.29
- Resistance Level
- ACHV $3.14
- ALAR $14.70
- Average True Range (ATR)
- ACHV 0.26
- ALAR 1.06
- MACD
- ACHV -0.00
- ALAR -0.32
- Stochastic Oscillator
- ACHV 40.43
- ALAR 33.55
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.